Explore the complete record of transactions filed by Karam Sammy, Vice-Président Senior. Director active across 1 companies, notably Abbott Laboratories. Aggregated, 7 filings have been logged. Total volume traded: €1.2m. The latest transaction was filed on 28 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Sammy Karam is the Senior Vice President at Abbott Laboratories. He is responsible for managing operations and strategic development for the company. With significant experience in the pharmaceutical sector, Sammy Karam contributes to process optimization and growth at Abbott Laboratories. His leadership is essential for achieving the company's objectives.